Semaglutide and social media: implications for young women with polycystic ovarian syndrome

Lancet Child Adolesc Health. 2023 May;7(5):301-303. doi: 10.1016/S2352-4642(23)00033-0. Epub 2023 Feb 17.

Authors

Sabrina K Keating¹, Cervantée E K Wild²

Affiliations

¹ Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford OX2 6GG, UK.
² Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford OX2 6GG, UK; Department of Paediatrics: Child and Youth Health, University of Auckland, Auckland, New Zealand. Electronic address: cervantee.wild@phc.ox.ac.uk.

PMID: 36803633
DOI: 10.1016/S2352-4642(23)00033-0

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Female
Glucagon-Like Peptides
Humans
Insulin Resistance*
Polycystic Ovary Syndrome*
Social Media*

Substances

semaglutide
Glucagon-Like Peptides